E-Mail
IMAGE: Data taken at the APS shows the neutralizing antibody D25 binding to the F protein of the Respiratory Syncytial Virus (RSV). This binding stabilizes the protein in its prefusion form....
view more
Credit: Jason McLellan
There is light at the end of the COVID-19 pandemic tunnel. Several vaccines against the SARS-CoV-2 virus that causes COVID-19 are now in clinical trials, with one -- developed by Pfizer/BioNTech -- already having been approved for emergency use in the United States. This has been the fastest development and rollout of any vaccine in history, starting with the first gene sequence released in January. (The previous record was held by the mumps vaccine, which took four years.)